Court suspends Mareva injunction, orders opening of Seplat’s corporate offices
Buhari directs FIRS, others to ensure strict compliance of tax payment by foreign firms
Google threatens to remove its search engine from Australia due to media code
Flour Mills moves to diversify funding sources with N29.8 billion bond listing
Renewable energy critical driver of Africa’s post-COVID-19 recovery and prosperity
Nigeria records $4.3 billion in Corporate Deals in 2020
FG says Excess Crude Account balance now stands at $72.4 million
Bitcoin posts biggest daily drop since market crash of March 2020
CBN has disbursed N14.35 billion to DisCos for meter procurement – FG
Naira gains marginally at NAFEX window, exchange rate to remain stable
Coronavirus
Covid-19: EU considers skipping vaccine patents to boost vaccine access
The EU has disclosed plans to increase its access to Covid-19 vaccines by offering financial incentives to vaccine production companies.
The European Union (EU) says its planning emergency measures to increase its access to Covid-19 vaccines including sidestepping patent rights and offering financial incentives to vaccine production companies to move production to Europe.
This was revealed in an EU document on Wednesday and reported by Reuters. The Document says the EU may create an emergency coordination mechanism to be issued at short notice when the EU needs a vaccine license, which is different from fully patent waivers, discussed in the WTO last week.
READ: COVID-19: EU to buy up to 300million doses of BioNTech-Pfizer’s COVID-19 vaccine
The EU says the new move will ensure faster procedures during a pandemic, which will enable generic production in the EU without the consent of patent holders.
“The Commission sees the need to ensure that effective systems for issuing compulsory licenses are in place, to be used as a means of last resort and a safety net, when all other efforts to make IP (intellectual property) available have failed,” the EU’s document said.
READ: COVID-19 boosts Fidson Healthcare Plc’s Q2 2020 performance
The EU’s actions may be triggered by its inability to access the antiviral drug, remdesivir, during the pandemic, as the United States ordered most of the stock.
READ: U.S dollar drops, Currency traders fear increasing COVID-19 caseloads
The EU also disclosed that it will begin a consultation process with pharmaceutical companies next year to address issues in its pharmaceutical value chains. They added that measures could be imposed to encourage manufacturers to move pharmaceutical production to Europe from China and India.
“The Commission calls on member states to ensure that the tools they have are as effective as possible; for instance, by putting in place fast-track procedures for issuing compulsory licenses in emergency situations,” the EU said.
READ: COVID-19: Vaccine Alliance says vaccine might cost a maximum of $40 per dose
They added that it is urgent “to assess whether manufacturing capacity for certain critical medicines may be required in the EU.”
“We need to be able to rely on ourselves, not on others,” the Commission’s Vice President, Margaritis Schinas said. He disclosed that the EU is working on more compliance with drug supply need and increased stock levels by 2022.
What you should know
This comes as surprise considering the EU rejected a World Trade Organization (WTO) proposal last week to waive the intellectual property rights needed for the manufacturing of Covid-19 vaccines. The waiver would have made the vaccine access cheaper for developing nations.
Coronavirus
COVID-19: Evidence suggests that new variants could pose challenge for vaccines
The research findings show that the new COVID variants may likely not respond well to the vaccines.
Recent research findings suggest that the new coronavirus variants would likely pose a big challenge for the vaccines, as revealed by studies by several medical researchers.
The new variant was first discovered in South Africa in October but has now been spread to more than a dozen countries all over the world.
According to the most recent findings, as reported by CNN, researchers took antibodies from six people who were hospitalized with Covid-19 before the new variant was discovered. They found to varying degrees, that the antibodies for all six of the survivors were unable to fully fight off the virus.
According to Alex Sigal, a virologist at the Africa Health Research Institute and the Max Planck Institute for Infection Biology, “I think the evidence is building that these mutations — and I think other mutations — will emerge across the globe — and are emerging already — that are escaping antibodies from previous infection. It’s concerning.”
According to Jesse Bloom, a virologist at the Fred Hutchinson Cancer Research Center, “When you see two groups independently arriving at same basic answer, that good — there’s more consonance that they are correct”
What you should know
- Sigal’s findings were very similar to those of a recent study by the National Institute for Communicable Diseases in South Africa.
- A research study has revealed that mutations in the new variant allowed them to evade some of the immunity induced by vaccination, but it was far from a complete escape.
- One thing that is critically safe for everyone is to get vaccinated, while the researchers are working to confirm whether these variants are dangerous or not to contain with the vaccines.
- According to Alex Sigal, “I would for sure get it if I could. My father-in-law had the opportunity to fly to Israel and get it, and I was shooing him out of the house because you can’t get it here in South Africa.”
- In a research study done at Rockefeller University, from a sample of 20 people who had received either the Moderna or the Pfizer vaccine, it was found that different mutations in the viruses did allow some escape from some types of antibodies, but the volunteers’ immune systems threw an army of different types of antibodies at the viruses.
- According to the research conducted in South Africa, blood was drawn from 44 people who had Covid-19 but the antibodies of about half of the 44 people were powerless against the new variant, while the other half, their antibody responses were weakened, but not totally knocked out.
Coronavirus
Covid-19: Buhari approves N6.45 billion to set up 38 oxygen production plants
President Buhari has approved the sum of N6.45 billion for the set-up of 38 oxygen production plants across the country.
President Muhammadu Buhari has announced his approval of N6.45 billion for the set-up of 38 oxygen production plants across the country, in a bid to contain the second wave of Covid-19.
The President disclosed this in a statement on Thursday evening after the first National Economic Council meeting of the year presided over by Vice President Yemi Osinbajo, SAN, with State Governors, Federal Capital Territory Minister, Central Bank Governor, and other senior government officials in attendance.
READ: Covid-19: FG directs universities to suspend academic activities till further notice
“As part of efforts to contain the second wave of Covid-19, we’re setting up new oxygen production plants in 38 locations across Nigeria—to enhance the management of patients in need of oxygen.
“I have equally approved funding for the rehabilitation of oxygen plants in 5 hospitals,” Buhari said.
The Minister of Finance, Budget and National Planning, Zainab Ahmed said the President said the fund’s release was necessitated by the rising cases of Covid-19 in the country with patients needing oxygen.
READ: Toyota suspends operations in China over Coronavirus outbreak
What you should know
- Recall Nairametrics reported that the Lagos State Governor, Babajide Sanwo-Olu, warned that the rising second wave of the pandemic in Lagos had seen the demand for oxygen rise 5 times from 70 six-liter cylinders per day to 350 six-liter cylinders at Yaba Mainland Hospital alone.
- He added that the state government had the decentralized provision of oxygen and other services needed for Covid-19 patients, citing the provision of oxygen kiosks.
Around the World
President Biden directs international air travelers must quarantine upon arrival
President Joe Biden has directed international air travellers to quarantine upon arrival in the United States.
The United States President Joe Biden has issued an executive order on Thursday that makes it mandatory for international air travellers to quarantine upon arrival in the US.
Similarly, the executive order also includes a directive that all interstate travellers in the US will be expected to wear a face mask. This travel order applies to airports and planes, trains, ferries, intercity buses and public transportation, but grants them the ability to issue exemptions.
READ: Here is reason Turkish Airlines was allowed to land in Abuja
What the US President is saying in the executive order
According to a report from Reuters, President Biden’s order says, ‘‘To the extent, feasible air travellers must comply with applicable U.S. Centers for Disease Control and Prevention (CDC) guidelines concerning international travel ‘including recommended periods of self-quarantine.”
However, the executive order does not explain how it will be enforced as the implementation still remains quite hazy.
READ: A Joe Biden presidency and its impact on Nigeria’s oil
The order also directs US agencies to engage with Canada and Mexico on public health protocols for land ports of entry including implementing CDC guidelines. Almost all non-essential travel at US land borders with Canada and Mexico has been suspended till February 21.
The CDC recommends a 7-day quarantine for people arriving in the United States from nearly all countries.
READ: Biden reverses US immigration ban on Nigeria, others
Biden is directing agencies to reconsider international contact tracing requirements for U.S.-bound passengers, which was abandoned by the Trump White House, as well as the possibility of follow-up Covid-19 testing for travellers after they arrive in the United States.
In addition, the US President has also directed that all travellers including US citizens, will be required to show proof of a negative Covid-19 test before entering the country from abroad in an order that underscores the CDC policy announced last week.
READ: Air travellers across Nigerian Airports hit 8.5 million in 6-month
What you should know
- It can be recalled that the Trump administration had resisted calls for the enforcement of a mask-wearing requirement.
- The Biden administration has also announced that it would reimpose coronavirus-related ban on most non-U.S. citizens arriving from European Union, Brazil, the United Kingdom.
- This follows the lifting of the restrictions by former US President, Donald Trump through an executive order on Monday.
Abj
November 26, 2020 at 10:31 am
It only Allah will help us about this situation